PDL BioPharma up for sale

PDL BioPharma Inc. (PDL) is actively seeking offers for the sale of the company as a whole or of its key assets following a review of its strategic alternatives.

In conjunction with the announcement of the potential sale on Monday, CEO and director Mark McDade also stepped down immediately. The company’s board elected former chairperson of the board L. Patrick Gage as interim CEO and Karen A. Dawes as the new chairperson of the board.

The company has said it is relocating from Fremont to Redwood City this fall.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Boudin halts prosecution of man shot by police in Mission

Newly elected District Attorney Chesa Boudin has withdrawn the criminal complaint against… Continue reading

‘Mad Mob’ aims to influence SF City Hall on mental health policies

They are fed up with City Hall telling those who need the services what’s best for them

‘Trump chicken returns to SF Bay with new companion

The Trump Chicken will return to San Francisco Bay on Saturday, but… Continue reading

Police efforts to stem 49ers revelry in Mission District spark backlash

SFPD preparing for potential bonfires, vandalism on Super Bowl Sunday

Calendar of Events: San Francisco celebrates the Year of the Rat

JAN. 25 Choy Sun Doe Day: The San Francisco Chinese Chamber of… Continue reading

Most Read